Literature DB >> 30253220

Outcomes that patients perceive and value are systematically unassessed in randomized clinical trials of endocrine-related illnesses: a systematic review.

Edgar Gerardo Dorsey-Treviño1, Neri Alvarez-Villalobos2, José Gerardo González-González3, Alejandro Díaz González-Colmenero1, Francisco Jesús Barrera-Flores1, Rozalina G McCoy4, Juan P Brito5, Alejandro Salcido-Montenegro1, Victor M Montori5, René Rodriguez-Gutierrez6.   

Abstract

Entities:  

Mesh：

Year:  2018        PMID： 30253220      PMCID： PMC6532980          DOI： 10.1016/j.jclinepi.2018.09.009

Source DB:  PubMed          Journal:  J Clin Epidemiol        ISSN： 0895-4356            Impact factor:   6.437


× No keyword cloud information.
  15 in total

1.  ICH harmonized tripartite guideline: Guideline for Good Clinical Practice.

Authors: 
Journal:  J Postgrad Med       Date:  2001 Jan-Mar       Impact factor: 1.476

2.  Let the patient revolution begin.

Authors:  Tessa Richards; Victor M Montori; Fiona Godlee; Peter Lapsley; Dave Paul
Journal:  BMJ       Date:  2013-05-14

3.  Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes.

Authors:  Bernard Zinman; Christoph Wanner; John M Lachin; David Fitchett; Erich Bluhmki; Stefan Hantel; Michaela Mattheus; Theresa Devins; Odd Erik Johansen; Hans J Woerle; Uli C Broedl; Silvio E Inzucchi
Journal:  N Engl J Med       Date:  2015-09-17       Impact factor: 91.245

4.  Individuals with diabetes preferred that future trials use patient-important outcomes and provide pragmatic inferences.

Authors:  Mohammad H Murad; Nilay D Shah; Holly K Van Houten; Jeanette Y Ziegenfuss; James R Deming; Timothy J Beebe; Steven A Smith; Gordon H Guyatt; Victor M Montori
Journal:  J Clin Epidemiol       Date:  2010-12-15       Impact factor: 6.437

5.  A randomized controlled trial of epoprostenol therapy for severe congestive heart failure: The Flolan International Randomized Survival Trial (FIRST).

Authors:  R M Califf; K F Adams; W J McKenna; M Gheorghiade; B F Uretsky; S E McNulty; H Darius; K Schulman; F Zannad; E Handberg-Thurmond; F E Harrell; W Wheeler; J Soler-Soler; K Swedberg
Journal:  Am Heart J       Date:  1997-07       Impact factor: 4.749

6.  Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus.

Authors:  Steven E Nissen; Kathy Wolski; Eric J Topol
Journal:  JAMA       Date:  2005-10-20       Impact factor: 56.272

7.  Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The Cardiac Arrhythmia Suppression Trial.

Authors:  D S Echt; P R Liebson; L B Mitchell; R W Peters; D Obias-Manno; A H Barker; D Arensberg; A Baker; L Friedman; H L Greene
Journal:  N Engl J Med       Date:  1991-03-21       Impact factor: 91.245

8.  Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.

Authors:  Jacques E Rossouw; Garnet L Anderson; Ross L Prentice; Andrea Z LaCroix; Charles Kooperberg; Marcia L Stefanick; Rebecca D Jackson; Shirley A A Beresford; Barbara V Howard; Karen C Johnson; Jane Morley Kotchen; Judith Ockene
Journal:  JAMA       Date:  2002-07-17       Impact factor: 56.272

9.  Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group.

Authors: 
Journal:  Lancet       Date:  1998-09-12       Impact factor: 79.321

10.  How do we know that research ethics committees are really working? The neglected role of outcomes assessment in research ethics review.

Authors:  Carl H Coleman; Marie-Charlotte Bouësseau
Journal:  BMC Med Ethics       Date:  2008-03-28       Impact factor: 2.652
View more
  2 in total

Review 1.  Value of Patient-Centered Glycemic Control in Patients with Type 2 Diabetes.

Authors:  René Rodríguez-Gutiérrez; Juan Manuel Millan-Alanis; Francisco J Barrera; Rozalina G McCoy
Journal:  Curr Diab Rep       Date:  2021-12-13       Impact factor: 4.810

Review 2.  Effect of metformin on microvascular outcomes in patients with type 2 diabetes: A systematic review and meta-analysis.

Authors:  José Gerardo González-González; Ricardo Cesar Solis; Alejandro Díaz González-Colmenero; Karina Raygoza-Cortez; Pablo J Moreno-Peña; Alicia L Sánchez; Rozalina G McCoy; Naykky Singh Ospina; Spyridoula Maraka; Juan P Brito; René Rodriguez-Gutierrez
Journal:  Diabetes Res Clin Pract       Date:  2022-03-02       Impact factor: 8.180
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.